185 related articles for article (PubMed ID: 9354430)
1. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.
Hunt KK; Deng J; Liu TJ; Wilson-Heiner M; Swisher SG; Clayman G; Hung MC
Cancer Res; 1997 Nov; 57(21):4722-6. PubMed ID: 9354430
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
[TBL] [Abstract][Full Text] [Related]
3. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
[TBL] [Abstract][Full Text] [Related]
5. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
6. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
Elliott MJ; Dong YB; Yang H; McMasters KM
Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
[TBL] [Abstract][Full Text] [Related]
7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
8. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
9. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
10. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
Meng RD; Phillips P; El-Deiry WS
Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
[TBL] [Abstract][Full Text] [Related]
11. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
12. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
13. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
[TBL] [Abstract][Full Text] [Related]
14. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.
Zhang SY; Liu SC; Johnson DG; Klein-Szanto AJ
Cancer Res; 2000 Nov; 60(21):5972-6. PubMed ID: 11085515
[TBL] [Abstract][Full Text] [Related]
15. E2F-1-induced p53-independent apoptosis in transgenic mice.
Holmberg C; Helin K; Sehested M; Karlström O
Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
Nip J; Hiebert SW
Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
[TBL] [Abstract][Full Text] [Related]
17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
19. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
Johnson DG; Schwarz JK; Cress WD; Nevins JR
Nature; 1993 Sep; 365(6444):349-52. PubMed ID: 8377827
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
